Olvidé mi contraseña
Asóciese a SIIC en Internet para utilizar sin límites tanto siicsalud como la totalidad de los servicios bibliográficos de la institución.
SIIC selecciona textos completos de calidad y de reciente publicación en fuentes prestigiosas del mundo
indizadas por SIIC Data Bases, capturadas en las mismas colecciones o en diversas bases especializadas.
La creciente cantidad de artículos con Acceso Abierto (Open
Access) amplía la oferta de lectura pero a su vez también, entre
tanta abundancia, complica al lector en su encuentro con los estudios
fundamentales. Para facilitarlo, profesionales biomédicos de SIIC
consultan diariamente una profusa cantidad de documentos que nutrirán
Textos completos autorizados (TCA).
Las citas de la sección TCA enlazan de manera legal, autorizada y
gratuita con los textos completos (full text) publicados en
los sitios oficiales de sus respectivas fuentes.
SIIC creó, produjo y opera con exclusividad el software TCA para la
interpretación de los diversos campos documentales que integran la
estructura de un estudio: especialidad, modalidad del estudio,
fuente, fechas de publicación y selección, definición de la fuente,
limitaciones de consulta, resumen en castellano, etc.
Si bien la mayoría de los textos seleccionados corresponden a
artículos originales, revisiones y guías, los lectores también
encontrarán comentarios, entrevistas, notas periodísticas, cartas a
autores u otros textos precursores de debates o aclaratorios.
Sociedad Iberoamericana de Información Científica (SIIC) selects
complete quality-full texts which have been recently published in
renowned sources worldwide and are indexed by SIIC Data
Bases.
The increasing number of Open Access articles widens the reading offer
but, also, such myriad complicates the readers search of fundamental
articles. To facilitate this, SIIC biomedical professionals daily
consult a profuse amount of documents that will feed
Authorized Full Texts (TCA, Spanish acronym).
The citations of the AFT section link legally, authorized and free of
charge with the full texts published in the official web sites of
their corresponding sources.
SIIC created, produced and handles the AFT software that deciphers
the various documentary fields that form part of the structure of a
study: specialty, study style, source, publication and selection
dates, source definition, query limitations, summary in Spanish,
etc.
While most of the selected texts belong to original articles,
reviews, and guidelines, readers will also find commentaries,
interviews, journalistic reports, letters to authors or other texts
that may lead to discussions or clarifications.
Effects of Bioactive Dietary Components on Changes in Lipid and Liver Parameters in Women after Bariatric Surgery and Procedures.
Effects of Bioactive Dietary Components on Changes in Lipid and Liver Parameters in Women after Bariatric Surgery and Procedures.
Fuente:Nutrients
Extracto:
The enrichment of the diet, after
bariatric surgery, with the addition of n-3 EFAs(Essential Fatty Acids),
bioflavonoids, vitamins, and synbiotics resulted in higher weight losses in the
patients in the study with a simultaneous reduction in parameters indicating
liver dysfunction.
Autor/es:Balejko, Edyta Barbara (a) Bogacka, Anna (b)
institución:(a) Department of Commodity Science, Quality Assessment, Process Engineering and Human Nutrition, West Pomeranian University of Technology in Szczecin, 71-459 Szczecin, Poland. (b) Department of Commodity Science, Quality Assessment, Process Engineering and Human Nutrition, West Pomeranian University of Technology in Szczecin, 71-459 Szczecin, Poland.
Conflicto:Los autores declaran no tener conflictos de interés con la investigación
Delayed gastric emptying after laparoscopic pancreaticoduodenectomy: a single-center experience of 827 cases.
Delayed gastric emptying after laparoscopic pancreaticoduodenectomy: a single-center experience of 827 cases.
Fuente:Bmc Surgery
Tipo de trabajo:Estudio de cohortes
Extracto:
Identifying
patients at an increased risk of DGE and secondary DGE can be used to intervene
earlier, avoid potential risk factors, and make more informed clinical decisions
to shorten the duration of perioperative management.
Claves:Delayed gastric emptying, Laparoscopic pancreaticoduodenectomy, Major complications, Pancreatic fistula
Cita:BMC Surg 2024 May 11; 24 (1) : 145.
Autor/es:Meng, Lingwei (a) Li, Jun (b)
institución:(a) Division of Pancreatic Surgery, Department of General Surgery, West China Hospital, Sichuan University, No. 37, Guoxue Alley, Chengdu, 610041, Sichuan Province, China. (b) Departments of General Surgery, Chengdu Shangjin Nanfu Hospital, Chengdu, Sichuan Province, China.
Conflicto:Lingwei Meng, Jun Li, Guoqing Ouyang, Yongbin Li, Yunqiang Cai, Zhong Wu, and Bing Peng declare no competing interests.
institución:(a) Department of Cellular Regenerative Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, 465 Kajii-cho, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto, 602-8566, Japan. takeday@koto.kpu-m.ac.jp. (b) Louis Pasteur Center for Medical Research, 103-5 Tanaka-Monzen-cho, Sakyo-ku, Kyoto, 606-8225, Japan.
Conflicto:Los autores declaran no tener conflictos de interés con la investigación
Positive resection margins in Crohn's disease are a relevant risk factor for postoperative disease recurrence.
Positive resection margins in Crohn's disease are a relevant risk factor for postoperative disease recurrence.
Fuente:Scientific Reports
Extracto:
Prospective studies are required to
determine whether extended resection or postoperative medical prophylaxis is
beneficial for patients with positive resection margins.
institución:(a) Department for General, Visceral, Transplant, Vascular and Pediatric Surgery, University Hospital of Würzburg, Oberduerrbacher Str., 697080, Würzburg, Germany. (b) Department for General, Visceral, Transplant, Vascular and Pediatric Surgery, University Hospital of Würzburg, Oberduerrbacher Str., 697080, Würzburg, Germany.
Conflicto:Los autores declaran no tener conflictos de interés con la investigación
institución:(a) Department of Gastroenterology and Neurology, Kagawa University School of Medicine, 1750-1 Ikenobe, Miki-cho, Kita-gun, Kagawa, 761-0793, Japan. (b) Department of Gastroenterology and Neurology, Kagawa University School of Medicine, 1750-1 Ikenobe, Miki-cho, Kita-gun, Kagawa, 761-0793, Japan. tani.joji@kagawa-u.ac.jp.
Conflicto:Los autores declaran no tener conflictos de interés con la investigación
Impact of Hepatitis B Surface and Core Antibody Levels on Hepatitis B Virus Reactivation.
Impact of Hepatitis B Surface and Core Antibody Levels on Hepatitis B Virus Reactivation.
Fuente:Biological & Pharmaceutical Bulletin
Extracto:
Our results suggest that
assessment of HBsAb and HBcAb levels prior to the chemotherapy is important for
identifying patients at high risk of HBV-R, especially in solid cancers without
HSCT and rituximab administration.
Claves:cancer chemotherapy, hepatitis B core antibody, hepatitis B surface antibody, hepatitis B virus reactivation, resolved hepatitis B virus infection, rituximab
Cita:Biol Pharm Bull 2024; 47 (5) : 941-945.
Autor/es:Ohkubo, Maki (a) Seo, Emiko (b)
institución:(a) Department of Pharmaceutical Sciences, Graduate School of Comprehensive Human Sciences, University of Tsukuba. (b) Department of Pharmacy, University of Tsukuba Hospital.
Gut microbiota composition in travellers is associated with faecal lipocalin-2, a mediator of gut inflammation.
Gut microbiota composition in travellers is associated with faecal lipocalin-2, a mediator of gut inflammation.
Fuente:Frontiers in Cellular and Infection Microbiology
Extracto:
DISCUSSION: The findings suggest a correlation between gut microbiome and LCN2
levels during travel, emphasising the need for further research to discern the
nature of this relationship.
Autor/es:Gandasegui, Javier (a) Vergara, Andrea (b)
institución:(a) Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain. (b) Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain.
Conflicto:The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Autor/es:Traska, Ann-Kristin (a) Nowacki, Tobias Max (b)
institución:(a) Department of Medicine B for Gastroenterology, Hepatology, Endocrinology and Clinical Infectiology, University Hospital Münster, 48149 Münster, Germany. (b) Department of Internal Medicine and Gastroenterology, Marienhospital Steinfurt, 48565 Steinfurt, Germany.
Conflicto:Los autores declaran no tener conflictos de interés con la investigación
Serum Galectin-3 as a Non-Invasive Marker for Primary Sclerosing Cholangitis.
Serum Galectin-3 as a Non-Invasive Marker for Primary Sclerosing Cholangitis.
Fuente:International Journal of Molecular Sciences
Extracto:
In conclusion, this study
demonstrates that serum and urinary galectin-3 levels can distinguish IBD from
PSC patients, and also reveals higher serum galectin-3 levels in PSC-IBD patients
compared to those with isolated PSC.
institución:(a) Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology, Rheumatology, and Infectious Diseases, University Hospital Regensburg, 93053 Regensburg, Germany. (b) Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology, Rheumatology, and Infectious Diseases, University Hospital Regensburg, 93053 Regensburg, Germany.
Conflicto:Arne Kandulski (scientific presentations and scientific advisory activities): Roche Pharma AG, Eisai GmbH, Abbvie Germany AG, Janssen-Cilag GmbH, MSD Sharp & Dohme GmbH, Boston Scientific Corp., Fujifilm Germany, Micro-Tech Germany, Bayer Pharma AG Germany. Hauke Christian Tews (scientific presentations and scientific advisory activities): Abbvie Germany AG, Janssen-Ciag GmbH, Celltrion, Bristol Myers Squibb, Pfizer Pharma GmbH. Martina Müller (travel grants, scientific...
c presentations): United European Gastroenterology, Abbvie Germany, Falk foundation, Germany. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
institución:(a) Department of Pediatrics of the Faculty of Medicine, University of Valladolid, Avenida Ramón y Cajal, 7, 47005 Valladolid, Spain. (b) Section of Pediatric Endocrinology, University Clinical Hospital of Valladolid, Avenida Ramón y Cajal, 7, 47005 Valladolid, Spain.
Conflicto:Los autores declaran no tener conflictos de interés con la investigación
Rifaximin plus lactulose versus lactulose alone for reducing the risk of HE recurrence.
Rifaximin plus lactulose versus lactulose alone for reducing the risk of HE recurrence.
Fuente:Hepatology Communications
Tipo de trabajo:Estudio abierto
Extracto:
Rifaximin plus lactulose was more efficacious than lactulose alone for reducing
the risk of overt HE recurrence and HE-related hospitalization in adults grouped
by select baseline disease characteristics.
Cita:Hepatol Commun 2024 Jun 1; 8 (6)
Autor/es:Sanyal, Arun J (a) Kowdley, Kris V (b)
institución:(a) Division of Gastroenterology, Hepatology, and Nutrition, Virginia Commonwealth University, Richmond, Virginia, USA. (b) Department of Gastroenterology and Hepatology, Elson Floyd College of Medicine, Spokane, Washington, USA.
Conflicto:Arun J. Sanyal consults and received grants from Boehringer Ingelheim, Bristol Myers Squibb, Eli Lilly, Gilead, Intercept, Inventiva, Madrigal, Mallinckrodt, Merck, Novartis, Novo Nordisk, and Pfizer. He consults and owns stock in GENFIT and HemoShear. He consults for 89bio, Albireo, Alnylam, Amgen, AstraZeneca, Covance, Genentech, HistoIndex, Janssen, NGM Bio, PathAI, Poxel, ProSciento, Regeneron, Roche, Salix, Siemens, and Terns. He received...
grants from Fractyl. He owns stock in Durect, Exhalenz, Indalo, NorthSea, Rivus, and Tiziana. He receives royalties from Elsevier and UpToDate. Kris V. Kowdley consults, is on the speakers' bureau, and received grants from Gilead and Intercept. He consults and received grants from 89bio, CymaBay, GENFIT, Madrigal, Mirum, NGM, and Pfizer. He consults and owns stock in Inipharm. He consults for Enanta, HighTide, and Salix. He is on speakers' bureau for AbbVie. He received grants from Corcept, GlaxoSmithKline, Hanmi, Novo Nordisk, Pliant, Terns, and Viking. Nancy S. Reau consults for AbbVie, Gilead, Intercept, and Salix. She received grants from Eiger. Nikolaos T. Pyrsopoulos consults for Salix. Christopher Allen is employed by Salix. Zeev Heimanson is employed by Salix. Jasmohan S. Bajaj consults for Merz. He received grant from Cosmo, Grifols, Mallinckrodt, Salix, and Sequana Medical.
Clinical characteristics of pyogenic liver abscess with and without biliary surgery history: a retrospective single-center experience.
Clinical characteristics of pyogenic liver abscess with and without biliary surgery history: a retrospective single-center experience.
Fuente:Bmc Infectious Diseases
Extracto:
Patients with
BS history, especially those who have undergone BEA, have an increased
susceptibility to PLA formation without affecting prognosis.
institución:(a) Department of Hepatobiliary Surgery, Shaanxi Provincial People's Hospital, 256 West Youyi Road, Xi'an, Shaanxi Province, 710068, China. (b) Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, 197 Rui Jin Er Road, Shanghai, 200025, China.
Conflicto:Los autores declaran no tener conflictos de interés con la investigación
Interactions between host and gut microbiota in gestational diabetes mellitus and their impacts on offspring.
Interactions between host and gut microbiota in gestational diabetes mellitus and their impacts on offspring.
Fuente:Bmc Microbiology
Extracto:
Finally, we compared offspring microbiota
composition from GDM with that from normal pregnancies, and described the
possible mechanism.
Claves:Gestational diabetes mellitus (GDM), Gut microbiota, Host-microbiome interactions, Metabolism, Offspring
Cita:BMC Microbiol 2024 May 10; 24 (1) : 161.
Autor/es:Wang, Shuxian (a) Cui, Zifeng (b)
institución:(a) Department of Obstetrics and Gynaecology, Peking University First Hospital, Beijing, China. (b) Beijing Key Laboratory of Maternal Fetal Medicine of Gestational Diabetes Mellitus, Beijing, China.
Conflicto:Los autores declaran no tener conflictos de interés con la investigación
Vitamin K Status Based on K1, MK-4, MK-7, and Undercarboxylated Prothrombin Levels in Adolescent and Adult Patients with Cystic Fibrosis: A Cross-Sectional Study.
Vitamin K Status Based on K1, MK-4, MK-7, and Undercarboxylated Prothrombin Levels in Adolescent and Adult Patients with Cystic Fibrosis: A Cross-Sectional Study.
Fuente:Nutrients
Extracto:
There do
not seem to be any good clinical predictive factors for vitamin K status.
Autor/es:Krzyżanowska-Jankowska, Patrycja (a) Nowak, Jan (b)
institución:(a) Department of Pediatric Gastroenterology and Metabolic Diseases, Poznan University of Medical Sciences, Szpitalna Street 27/33, 60-572 Poznan, Poland. (b) Department of Pediatric Gastroenterology and Metabolic Diseases, Poznan University of Medical Sciences, Szpitalna Street 27/33, 60-572 Poznan, Poland.
Conflicto:Los autores declaran no tener conflictos de interés con la investigación
Clinical variables influencing the severity of diabetes ketoacidosis.
Clinical variables influencing the severity of diabetes ketoacidosis.
Fuente:Saudi Medical Journal
Tipo de trabajo:Revisión
Extracto:
Diabetes ketoacidosis was observed to occur more frequently among
males in middle childhood with seasonal variations. Furthermore, the severity of
DKA was associated with lower economic status, early adolescence, and the
presence of hypernatremia.
Autor/es:Alhamdani, Yara F (a) Almadfaa, Lojain O (b)
institución:(a) From the Department of Pediatrics, Faculty of Medicine, King Abdulaziz University, Jeddah, Kingdom of Saudi Arabia. (b) From the Department of Pediatrics, Faculty of Medicine, King Abdulaziz University, Jeddah, Kingdom of Saudi Arabia.
Extracto:
They will give healthcare providers a better awareness of the optimal
analgesic medication for pain treatment in non-severe, acute pancreatitis.
Autor/es:Subramani, Sriya S (a) Berg, Alaina C (b)
institución:(a) Stead Family Department of Pediatrics, The University of Iowa, Roy J and Lucille A Carver College of Medicine, Iowa City, Iowa, USA. (b) The University of Iowa, Roy J and Lucille A Carver College of Medicine, Iowa City, Iowa, USA.
Conflicto:Los autores declaran no tener conflictos de interés con la investigación
The pan-PPAR agonist lanifibranor improves cardiometabolic health in patients with metabolic dysfunction-associated steatohepatitis.
The pan-PPAR agonist lanifibranor improves cardiometabolic health in patients with metabolic dysfunction-associated steatohepatitis.
Fuente:Nature Communications
Extracto:
Here, we show that effects of lanifibranor on liver
histology in MASH are accompanied with CMH improvement, indicative of potential
cardiovascular clinical benefits.
Cita:Nat Commun 2024 May 10; 15 (1) : 3962.
Autor/es:Cooreman, Michael P (a) Butler, Javed (b)
institución:(a) Research and Development, Inventiva, New York, NY, USA. Michael.Cooreman@inventivapharma.com. (b) Research and Development, Inventiva, Daix, France. Michael.Cooreman@inventivapharma.com.
Conflicto:M.P.C., L.D., P.H.M., M.B. and P.B. are employees of Inventiva. J.L.J. is a consultant for Inventiva. D.R.B. has received honoraria from Inventiva via Translational Medicine Academy. J.B. has served as a consultant for Abbott, American Regent, Amgen, Applied Therapeutic, AskBio, Astellas, AstraZeneca, Bayer, Boehringer Ingelheim, Boston Scientific, Bristol Myers Squibb, Cardiac Dimension, Cardiocell, Cardior, Cardiorem, CSL Bearing, CVRx, Cytokinetics, Daxor,...
Edwards, Element Science, Faraday, Foundry, G3P, Innolife, Impulse Dynamics, Imbria, Inventiva, Ionis, Lexicon, Lilly, LivaNova, Janssen, Medtronics, Merck, Occlutech, Owkin, Novartis, Novo Nordisk, Pfizer, Pharmacosmos, Pharmain, Prolaio, Regeneron, Renibus, Roche, Salamandra, Sanofi, SC Pharma, Secretome, Sequana, SQ Innovation, Tenex, Tricog, Ultromics, Vifor, and Zoll. RPG received research support or honoraria form Amgen, Anthos Therapeutics, Daiichi Sankyo, Ionis, Dr. Reddy’s Laboratories, Medical Education Resources, Menarini, SAJA Pharmaceuticals, Servier, SUMMEET, and consults for Artivion, Beckman Coulter, Daiichi Sankyo, Gilead, Inari, Inventiva, PhaseBio Pharmaceuticals, Samsung and Aventis. FZ reports personal fees from 89Bio, Abbott, Acceleron, Applied Therapeutics, Bayer, Betagenon, Boehringer, BMS, CVRx, Cambrian, Cardior, Cereno pharmaceutical, Cellprothera, CEVA, Inventiva, KBP, Merck, NovoNordisk, Owkin, Otsuka, Roche Diagnostics, Northsea, USa2, having stock options at G3Pharmaceutical and equities at Cereno, Cardiorenal, Eshmoun Clinical research and being the founder of Cardiovascular Clinical Trialists. MFA received grants from Boehringer-Ingelheim, Gilead, Hanmi, Inventiva, Madrigal, Novo Nordisk; honoraria from Clinical Care Options, Fishawack, Medscape, Terra Firma, CLDF; royalties from Up-to-Date; consults for 89Bio, BMS, Hanmi, Inventiva, Intercept, Madrigal, Merck, Novo Nordisk. SMF received grants from Astellas, Falk Pharma, Genfit, Gilead Sciences, GlympsBio, Janssens Pharmaceutica, Inventiva, Merck Sharp & Dome, Pfizer, Roche; honoraria from Abbvie, Allergan, Bayer, Eisai, Genfit, Gilead Sciences, Janssens Cilag, Intercept, Inventiva, Merck Sharp & Dome, Novo Nordisk, Promethera, Siemens; serves as consultant for Abbvie, Actelion, Aelin Therapeutics, AgomAb, Aligos Therapeutics, Allergan, Alnylam, Astellas, Astra Zeneca, Bayer, Boehringer Ingelheim, Bristoll-Meyers Squibb, CSL Behring, Coherus, Echosens, Dr. Falk Pharma, Eisai, Enyo, Galapagos, Galmed, Genetech, Genfit, Genflow Biosciences, Gilead Sciences, Intercept, Inventiva, Janssens Pharmaceutica, PRO.MED.CS Praha, Julius Clinical, Madrigal, Medimmune, Merck Sharp & Dome, Mursla Bio, NGM Bio, Novartis, Novo Nordisk, Promethera, Roche, Siemens Healthineers.
Low ankle-brachial index is associated with higher cardiovascular mortality in individuals with nonalcoholic fatty liver disease.
Low ankle-brachial index is associated with higher cardiovascular mortality in individuals with nonalcoholic fatty liver disease.
Fuente:European Journal of Medical Research
Tipo de trabajo:Estudio de cohortes
Extracto:
Low ABI is independently
associated with higher cardiovascular mortality in NAFLD cases. This correlation
remains significant even in the absence of pre-existing cardiovascular disease or
diabetes.
institución:(a) Department of Geriatric Endocrinology and Metabolism, The First Affiliated Hospital of Guangxi Medical University, No. 6 Shuangyong Road, Nanning, 530021, Guangxi, China. (b) Department of Geriatric Endocrinology and Metabolism, The First Affiliated Hospital of Guangxi Medical University, No. 6 Shuangyong Road, Nanning, 530021, Guangxi, China.
Conflicto:The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
JMJD6 Autoantibodies as a Potential Biomarker for Inflammation-Related Diseases.
JMJD6 Autoantibodies as a Potential Biomarker for Inflammation-Related Diseases.
Fuente:International Journal of Molecular Sciences
Extracto:
Hence, JMJD6 autoantibodies may
reflect inflammation, thereby serving as a potential biomarker for diagnosing
specific inflammation-related diseases, including stroke, AMI, DM, and cancers,
and for prediction of the prognosis in patients with EC.
institución:(a) Department of Neurological Surgery, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan. (b) Department of Biochemistry and Genetics, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan.
Conflicto:This present study was performed in collaboration with Fujikura Kasei Co., Ltd., and Hideyuki Kuroda is an employee of Fujikura Kasei Co., Ltd. The other authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
The Mediterranean Diet, Its Microbiome Connections, and Cardiovascular Health
The Mediterranean Diet, Its Microbiome Connections, and Cardiovascular Health
Fuente:International Journal of Molecular Sciences
Tipo de trabajo:Revisión
Extracto:
This review will
focus on the effects of MD on cardiovascular health through its action on gut
microbiota.
Claves:Mediterranean-type diet, Western-type diet, atherosclerosis, bile acids, cardiovascular disease, gut microbiota, nutrients, short-chain fatty acid, trimethylamine N-oxide
Cita:Int J Mol Sci 2024 Apr 30; 25 (9)
Autor/es:Abrignani, Vincenzo (a) Salvo, Andrea (b)
institución:(a) Internal Medicine and Stroke Care Ward, University of Palermo, 90127 Palermo, Italy. (b) Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, University of Palermo, 90127 Palermo, Italy.
Conflicto:Los autores declaran no tener conflictos de interés con la investigación
Alergia
Anestesiología
Bioquímica
Cardiología
Cirugía
Dermatología
Endocrinología y Metabolismo
Enfermería
Gastroenterología
Hematología
Infectología
Inmunología
Medicina Interna
Nefrología
Neumonología
Neurología
Nutrición
Obstetricia y Ginecología
Odontología
Oncología
Otorrinolaringología
Pediatría
Salud Mental
Salud Pública
Urología
Más Especialidades
